Drawing for DOCTOR CHOCO

USPTO serial 79182058

DOCTOR CHOCO

Reviewed by CopyMark Law Group

Reg. 5135022Status 404
Filing date
Status date
Registration date
Feb 7, 2017
Examiner
BRADLEY, EVELYN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DOCTOR CHOCO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Nutritional supplements; syrups for pharmaceutical purposes for treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; pharmaceutical preparations for treatment of cough, cough compulsion, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; chemico-pharmaceutical preparations for treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; vitamin preparations; chemical preparations for medical use in the form of solutions, syrups, drops, liquid preparations, suspensions, emulsions for treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; chemical preparations for pharmaceutical use, specifically for the treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; biological preparations for medical purposes in the form of solutions, syrups, drops, liquid preparations, suspensions, emulsions for treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; malted milk beverages for medical use; human medicine for the treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; medicines for veterinary use for the treatment of cough, urge to cough, expectoration, formation of mucus, hoarseness, loss of voice, inflammation of vocal cords, sore throat, sinus problems, calcium deficiency, vitamin D deficiency, and for supportive treatment of allergic and inflammatory diseases; medicinal tea; medicinal drinksSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 28, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
May 28, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
May 12, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 18, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 18, 2024INPCINVALIDATION PROCESSED—
Apr 18, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 18, 2023C71TCANCELLED SECTION 71—
Feb 7, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 23, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 4, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 3, 2017FIMPFINAL DISPOSITION PROCESSED—
May 7, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 7, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 22, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 22, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 2, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 17, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 15, 2016CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 6, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 3, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 23, 2016ALIEASSIGNED TO LIE—
Aug 16, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 16, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 28, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 11, 2016RFNTREFUSAL PROCESSED BY IB—
Feb 25, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 25, 2016RFRRREFUSAL PROCESSED BY MPU—
Feb 25, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 24, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 16, 2016DOCKASSIGNED TO EXAMINER—
Feb 16, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 11, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance